CHC Healthcare Group (TPE:4164)

Market Cap	7.20B
Revenue (ttm)	3.60B
Net Income (ttm)	168.38M
Shares Out	166.87M
EPS (ttm)	0.98
PE Ratio	43.98
Forward PE	15.30
Dividend	1.51 (3.53%)
Ex-Dividend Date	Jul 10, 2024

Volume	438,843
Average Volume	1,647,793
Open	43.00
Previous Close	42.80
Day's Range	42.75 - 43.25
52-Week Range	35.50 - 60.40
Beta	0.41
RSI	43.84
Earnings Date	May 6, 2025

About CHC Healthcare Group

CHC Healthcare Group, together with its subsidiaries, engages in trading of pharmaceutical products and health food in Taiwan, China, and internationally. The company is also involved in the sale, leasing, installing, and repairing of medical instruments. In addition, it engages in the sale of ophthalmic equipment; irradiation business; sale of drug and health supplements; consulting, elderly residence, and senior fitness services; Long-term care services; and leasing of veterinary medical instruments. CHC Healthcare Group was founded in 1977 a...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1977
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4164

Financial Performance

In 2024, CHC Healthcare Group's revenue was 3.60 billion, a decrease of -7.13% compared to the previous year's 3.88 billion. Earnings were 168.38 million, a decrease of -59.80%.